Overview

Pharmacokinetic Properties of Isosorbide-5-mononitrate Under Fasting and Fed Condition in Healthy Male Subjects

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This study it to evaluate the bioequivalence of Elantan SR 60 mg compared to Imdur SR 60 mg in sixty healthy Korean male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
UCB Korea Co., Ltd.
Collaborator:
Seoul Pharma Laboratories Inc.
Treatments:
Isosorbide
Isosorbide Dinitrate
Isosorbide-5-mononitrate